(Q42988555)

12 November 2017

title

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates (English)

1 reference

Japanese encephalitis virus

12 November 2017

main subject

0 references

Japanese encephalitis

1 reference

1 reference

Konishi E

1

1 reference

12 November 2017

Kurane I

2

1 reference

12 November 2017

Mason PW

3

1 reference

12 November 2017

Shope RE

4

1 reference

12 November 2017

Kanesa-Thasan N

5

1 reference

12 November 2017

Smucny JJ

6

1 reference

12 November 2017

Hoke CH Jr

7

1 reference

12 November 2017

Ennis FA

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

12 November 2017

1 reference

12 November 2017

volume

16

1 reference

12 November 2017

issue

8

1 reference

12 November 2017

page(s)

842-849

1 reference

From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Host defence mechanisms against Japanese encephalitis virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

A single gene controls resistance to Japanese encephalitis virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Towards a new generation of flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Immunization with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900265-X

7 January 2021

10.1016/S0264-410X(97)00265-X

Identifiers

DOI

1 reference

12 November 2017

1 reference